Cotazym and Aneurysm - a phase IV clinical study of FDA data


Aneurysm is reported only by a few people who take Cotazym.

The phase IV clinical study analyzes which people take Cotazym and have Aneurysm. It is created by eHealthMe based on reports of 324 people who have side effects while taking Cotazym from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2022

324 people reported to have side effects when taking Cotazym.
Among them, 4 people (1.23%) have Aneurysm.

What is Cotazym?

Cotazym has active ingredients of pancrelipase (amylase;lipase;protease). eHealthMe is studying from 328 Cotazym users for its effectiveness, alternative drugs and more.

What is Aneurysm?

Aneurysm (enlargement of an artery caused by a weakening of the artery wall) is found to be associated with 1,165 drugs and 678 conditions by eHealthMe.

Number of Cotazym and Aneurysm reports submitted per year:

Could Cotazym cause Aneurysm?

Gender of people who have Aneurysm when taking Cotazym *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Aneurysm when taking Cotazym *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Cotazym *:

  1. Lyrica: 4 people, 100.00%
  2. Flomax: 4 people, 100.00%
  3. Baby Aspirin: 3 people, 75.00%
  4. Zopiclone: 2 people, 50.00%
  5. Vitamin B12: 2 people, 50.00%
  6. Ventolin: 2 people, 50.00%
  7. Tylenol: 2 people, 50.00%
  8. Singulair: 2 people, 50.00%
  9. Seebri: 2 people, 50.00%
  10. Plavix: 2 people, 50.00%

Common side effects people have besides Aneurysm *:

  1. Weight Decreased: 4 people, 100.00%
  2. Diarrhea: 4 people, 100.00%
  3. Hyperhidrosis (abnormally increased sweating): 4 people, 100.00%
  4. High Blood Pressure: 4 people, 100.00%
  5. Weakness: 4 people, 100.00%
  6. Headache (pain in head): 4 people, 100.00%
  7. General Physical Health Deterioration (weak health status): 4 people, 100.00%
  8. Gastrointestinal Inflammation (inflammation of stomach and intestine): 4 people, 100.00%
  9. Gastrointestinal Bacterial Infection (infection of the stomach and intestines caused by bacteria): 4 people, 100.00%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 100.00%

Common conditions people have *:

  1. Pancreatic Carcinoma (pancreatic cancer): 4 people, 100.00%
  2. Neuroendocrine Tumor: 2 people, 50.00%
  3. General Physical Health Deterioration (weak health status): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cotazym and have Aneurysm?

Check whether Aneurysm is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Aneurysm and when was it recovered:

Expand to all the drugs that have ingredients of pancrelipase (amylase;lipase;protease):

Alternative drugs to, pros and cons of Cotazym:

Aneurysm treatments and more:

COVID vaccines that are related to Aneurysm:

Common drugs associated with Aneurysm:

All the drugs that are associated with Aneurysm:

Common conditions associated with Aneurysm:

All the conditions that are associated with Aneurysm:

How the study uses the data?

The study uses data from the FDA. It is based on pancrelipase (amylase;lipase;protease) (the active ingredients of Cotazym) and Cotazym (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: